March 5, 2020, is a special day in the history of the Sutter. After a long planning phase and intensive preparations, the ground-breaking ceremony in Emmendingen finally took place today. 

We are pleased to welcome a new member to the extended management board at Sutter. Dr. Simone Peschl, who has been responsible for Business Development & Product Management since 2018, will join the management team around CEO Bert Sutter as VP Business Development & Market Access from March 2020.

Last week we successfully completed our re-certification audit. During the 3-day visit our company and products were audited and confirmed according to ISO13485:2016 and Medical Device Directive (MDD). The new certificate is now valid for another 4 years.

At the beginning of the year we often look back on the past year and make plans for the new year. In this context we would like to share a few words by CEO Bert Sutter with you.

We are excited to announce that our established RaVoR™ bipolar electrodes will be launched for the US market at the AAO-HNSF in New Orleans this weekend. The instruments are available for the radiofrequency volume reduction of the inferior turbinates and the soft palate. Visit us at booth #1716 at the AAO-HNSF or learn more here.

As part of their "climate and economy" tour, Green Party politicians Kerstin Andreae and Dr. Sandra Detzer visited Sutter today.

In the late 90’s, Jonathan Thorne (CEO & President, Silverglide Surgical Technologies) was shown what he described as the “perfectly balanced bipolar forceps” by a surgeon he knew in California. It did, however, as all bipolar forceps at the time, stick to tissue. He called it a “good coincidence” that he was introduced to Bert Sutter shortly after, only to find out that it was Sutter who manufactured the bipolar forceps he had seen in California. 

We are excited to showcase the bayonet version of the Calvian endo-pen® bipolar forceps at this year's AANS in San Diego, CA. Visit booth no. 1606 to see this innovative extension of our Calvian endo-pen® product line.

The CURIS® 4MHz radiofrequency generator offers surgeons in various disciplines the benefits of the ultra-high 4 MHz frequency for both monopolar and bipolar operating modes. We are excited to announce that the generator is now available in the US. For more information, please visit the CURIS® product page. 

The end of the year is often a time to reflect on the past year and to make plans for the new year. So, before we ring in the new year, we would like to share a few words by CEO Bert Sutter with you.